precision

CHCNAV Engages Agritechnica 2025, Full-Stack Precision Agriculture Solution Sparks Global Partnership Interest

Hanover, Germany, Nov. 22, 2025 (GLOBE NEWSWIRE) -- CHC Navigation shared a significantly positive market engagement following the successful conclusion…

5 days ago

Reebok Launches Nano X5 Edge Training Shoes

The Official Shoe of Fitness Just Leveled UpBOSTON, Mass. – Nov. 21st, 2025 – Today, Reebok introduces the Nano X5…

6 days ago

FinoTraze Unveiled: FinoTraze Emerges as 2025s Most Trusted AI Trading Solution for Smarter Investing with Precision

New York City, NY, Nov. 15, 2025 (GLOBE NEWSWIRE) -- What Is FinoTraze? – Inside the AI Trading Platform Making…

2 weeks ago

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine,…

2 weeks ago

Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA

Company Leverages Legacy of Trust and Expertise as it Makes Inaugural Appearance at COMPAMED/MEDICA BOSTON, Nov. 4, 2025 /PRNewswire/ -- Elevaris…

3 weeks ago

ICHORtec and Johns Hopkins University Expand Collaboration to Enhance CRISPR Gene Editing Specificity Using Quantum FMB Technology

BERLIN and BALTIMORE, Oct. 29, 2025 /PRNewswire/ -- ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby…

4 weeks ago

A Breakthrough in Color Measurement Is Coming: The HunterLab Agera L2

RESTON, Va., Oct. 29, 2025 /PRNewswire/ -- A breakthrough in color measurement is on the horizon. This November, HunterLab will…

4 weeks ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

1 month ago

Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies

October 24, 2025 23:37 ET  | Source: RepIntel. New York, New York, USA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aletheia…

1 month ago

Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer

Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival…

1 month ago